Methods of medical treatment for excess phosphate using guanidino-containing polymers
US6132706A · kind A · utility
14Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 1997 |
| Grant date | Oct 17, 2000 |
| Priority date | — |
| Expiry date | Nov 28, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions comprising the physiologically acceptable polymer. Such foodstuffs and compositions are of value in controlling phosphate levels in the body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.